Caleo Biotechnologies, Inc.
- Biotech or pharma, therapeutic R&D
- Diagnostics
- Other R&D services
At CaleoBio, we’re advancing next-generation, patient-derived Organ-Dish (OD) models that move beyond reductionist organoids and animal systems. ODs are self-organizing models that recapitulate native tissue structure and function ex-vivo. By integrating epithelial, mesenchymal, and immune components, they enable high-fidelity modeling of immune dysregulation, wound repair, and barrier dysfunction. Coupled with computational imaging, the OD platform provides a scalable framework for studying therapeutic response on a patient-specific level—positioning CaleoBio at the forefront of the FDA-driven shift away from animal testing.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}